- Research
- Open access
- Published:
A high number of tumor deposits (≥ 4) is an isolated predictor of local recurrence and distant metastasis in non-metastatic colorectal cancer: a single center study
Surgical and Experimental Pathology volume 7, Article number: 30 (2024)
Abstract
Introduction
Local recurrence and distant metastasis after curative surgery and chemotherapy for colorectal cancer (CRC) is a serious complication and is considered a failure of the therapeutic strategy. The aim of this study is to identify the different prognostic factors associated with tumor recurrence and distant metastasis in CRC.
Design
An analytical cross-sectional design was employed, and our hospital clinical and pathology databases were queried for non-metastatic CRC (stage I-III). Patients were included if they underwent surgery and chemotherapy between 01/2016 to 12/2018 and demographic information, tumor characteristics and postoperative outcomes were extracted from each case. The data were entered into a database using SPSS version 21. Univariate analysis was initially performed, followed by a multivariate analysis to develop a prognostic model for tumor recurrence and distant metastasis in CRC.
Result
A total of 138 non-metastatic CRC patients were enrolled in this study. The demographic characteristics of all patients are summarized in Table 1. Our study included 65 male and 73 female patients with a Median (IQR) age of 69 (17.7) years. Among the cases, 91 (65.9%) patients had no recurrence, and 47 (34.1%) patients developed a recurrence during follow-up. Univariate analysis revealed that positive lymph nodes (p = 0.03) and tumor deposits ≥ 4 (p = 0.04) were significantly associated with colorectal tumor recurrence and/or metastasis. However, variables such as age, sex, smoking, alcohol consumption, family history of CRC, PNI, LVI, tumor size, and histological features like mucinous or signet ring cell morphology did not show any statistical significance (p > 0.05). Multivariate analysis adjusted for age, lymph node status, and tumor deposits, identified that tumor deposits ≥ 4 was the only predictor of tumor recurrence following colorectal surgery and chemotherapy. Conversely, positive lymph node status did not show statistical significance (p = 0.3). Further analysis revealed that patients who had tumor deposit number ≥ 4 tend to experience local recurrence/distant metastasis more than patients with tumor deposit number < 4.
Conclusion
In non-metastatic CRC patients, TD ≥ 4 is a strong predictor of local tumor recurrence and distant metastasis. Based on these findings, patients who have TDs in primary CRC resection should be subjected to enhanced surveillance.
Introduction
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States (Siegel et al. 2021; Chen et al. 2016).TNM classification is essential to the staging of colon cancer, it is used in treatment decisions as well as to predict disease prognosis (Siegel et al. 2021; National Comprehensive Cancer Network 2023; Nagtegaal et al. 2007; Nagtegaal et al. 2011).
Tumor deposits (TDs) are defined in AJCC 8th edition as discrete tumor nodules within the lymph drainage area of the primary carcinoma without identifiable lymph node tissue or identifiable vascular or neural structure (Amin 2017). TDs are found in approximately 17–22% of patients with CRC and correlate with poor prognosis, which includes shorter disease-free and overall survival (Tateishi et al. 2005; Nagtegaal et al. 2017).
This impact is apparent in the latest TNM system, where the presence of TDs is classified as pN1c in the absence of lymph node involvement (Delattre et al. 2020). Furthermore, current NCCN guidelines state that the number of tumor deposits should be recorded in the pathology report due to their significant impact on survival rates (National Comprehensive Cancer Network 2023).
Despite previous studies establishing the link between TDs, advanced tumor growth, and poor prognosis, a consensus on the quantity of TDs is lacking. To address this gap, we conducted a retrospective study at our institution, investigating the impact of TDs on the prognostic factors of colorectal carcinoma.
Design
Data collection and tumor deposit definition
An analytical cross-sectional design was employed, and our hospital clinical and pathology databases were queried for non-metastatic CRC (stage I-III) patients who underwent surgery and chemotherapy between 01/2016 and 12/2018. The definition of TDs was determined according to the AJCC 8th TNM as a tumor focus in the pericolic/perirectal fat or in the adjacent mesentery (mesocolic or rectal fat) within the lymph drainage area of the primary tumor, but without identifiable lymph node tissue or vascular structure. If the vessel wall or its remnant is identified by H&E staining, we classified it as vascular (venous) invasion and not as a tumor deposit. Similarly, if a tumor focus is present in or around a large nerve, we classified it as perineural invasion and not as a tumor deposit (Fig. 1 shows H&E images of 5 included cases diagnosed with tumor deposits).
To establish a prognostic model for predicting out comes (local recurrence /distant metastasis), we reviewed the clinicopathological features of all patients, including age, sex, tumor location, tumor grade, perineural invasion, presence of TDs, etc. Exclusion criteria included (1) neoadjuvant therapy; (2) no information available on TDs; (3) colorectal cancer is not the only primary cancer; (4) patients with incomplete information about follow-up; (5) presence of distant metastasis at the first-time CRC diagnosis.
Study outcomes
The end point of the study was estimating the outcome in the form of (local recurrence and or distant metastasis) over 5 years follow up. Local recurrence was defined as tumor recurrence in the bowel close to the original site. Distant metastasis was defined as the presence of liver, lung, bone, or brain metastases during or after CRC diagnosis.
Statistical analysis
All statistical analyses were performed using SPSS version 21. The chi-square test was used to analyze categorical variables’ demographic and clinical characteristics. The logistic regression coefficients were used to estimate the odds ratios (OR) for the relationship between TDs and distant metastasis patterns. Calculated hazard ratio (HR), 95.0% confidence interval (CI), and Cox proportional hazards model were used for univariate and multivariate analysis. In multivariate analyses, the clinicopathological characteristics with p < 0.05 in univariate analysis were included to determine independent prognostic factors. Significance was set at p < 0.05.
Result
Baseline characteristics of the study population
A total of 138 non-metastatic CRC patients were enrolled in this study. The demographic characteristics of all patients are summarized in Table 1. Our study included 65 male and 73 female patients with a Median (IQR) age of 69 (17.75) years. Among the cases, 91(65.9%) patients had no recurrence, and 47 (34.1%) patients developed a recurrence for 5 years follow-up. The Median (IQR) BMI of the included patients was calculated as 27 (8) (Table 1).
Histopathologic findings
With regard to tumor size, the median (IQR) size of the tumor was found to be 5.40 cm (3.30). Mucinous features were identified in 24(17.4%) cases, medullary features were identified in 6(4.3%) cases, and Signet ring histology were identified in 3(2.2%) cases. Most of the cases were moderately differentiated 68(49.3%). The median (IQR) number of extracted lymph node was 19(10), the number of cases that had positive lymph node were 85(61.6%) with Median (IQR) number of positive lymph node was 1(4). Lymphvascular invasion was identified in 98(71%) cases and perineural invasion was identified 52(37.7%) (Table 2).
Predictors of tumor recurrence and/ or distant metastasis
Table 3 expresses the adjusted and unadjusted analysis between the tumor recurrence/ distant metastasis and the main independent variables. Among the patients who developed local recurrence or distant metastasis, 31 have a number of tumor deposit < 4 and 16 patients have ≥ 4. Univariate analysis revealed that positive lymph nodes (p = 0.03) and tumor deposits ≥ 4 (p = 0.004) were significantly associated with colorectal tumor recurrence and/or metastasis. However, variables such as age, sex, smoking, alcohol consumption, family history of CRC, PNI, LVI, tumor size, and histological features like mucinous or signet ring cell morphology did not show any statistical significance (p > 0.05). Multivariate analysis, adjusted for age, lymph node status, and tumor deposits, identified that tumor deposits ≥ 4 were the only predictor of tumor recurrence following colorectal surgery and chemotherapy. Conversely, positive lymph node status did not show statistical significance (p = 0.3) (Tables 3 and 4).
Discussion
The results of this study indicate that four or more tumor deposits (TDs) are a robust predictor for local tumor recurrence and distant metastasis in patients with non-metastatic colorectal cancer (CRC). Considering these observations, it is advisable to implement enhanced surveillance for patients undergoing primary CRC resection who exhibit TDs. We didn’t find any significant association between local recurrence/distant metastasis and age, sex, smoking, alcohol consumption, family history of CRC, LVI, PNI, tumor size, MSI status, mucinous histology, signet ring morphology, positive lymph nodes and use of adjuvant chemotherapy.
Since its inclusion in the AJCC TNM staging system, numerous studies on tumor deposits in colorectal carcinoma consistently indicate their significance as an important prognostic factor (Ueno et al. 2014). However, only a limited number of studies have successfully elucidated the influence of TDs on both local recurrence and distant metastasis.
Delattre et al. showed that the presence of TDs is a major prognostic factor related to a higher risk of recurrence or death in patients with TDs, both qualitatively and quantitatively in a large prospective phase III trial first time (IDEA France). (Delattre et al. 2020) Wu et al. retrospectively analyzed CRC patients from two large independent cohorts, the Surveillance Epidemiology and End Results (SEER) database (n= 58,775) and colon cancer center in China (= 742). He reported that CRC cancer patients without TDs have better survival benefits than patients with TDs (Wu et al. 2022). Nagayoshi et al. also investigated TDs in patients with CRC (n= 171) and revealed that patients with TD-positive CRC had significantly lower recurrence-free rates compared to TD-negative CRC. Their follow-up showed that patients with TD-positive CRC developed more frequent local and/or distant tumor recurrence (Nagayoshi et al. 2014).
Association of other variables with local recurrence/distant metastasis such as age, sex, smoking, alcohol, family history, MSI status, mucinous histology, signet ring histology, tumor size, lymph node status, number of total and extracted lymph nodes, lymphovascular invasion, perineural invasion, adjuvant therapy has been widely studied. Xu et al. published an umbrella review of all systematic reviews of observational studies (with/without meta-analysis) and investigated risk factors of CRC recurrence and metastasis (Xu et al. 2020). Based on their evaluation, extranodal extension, perineural invasion, MRI-detected extramural vascular invasion and intramural vascular invasion are highly suggestive risk factors for the recurrence of the CRC. They also reviewed prognostic models developed for prediction of local recurrence and identified following predictors: distance from the anal verge, TNM stage, surgery type, residual tumor status, radiotherapy, age, concomitant chemotherapy and adjuvant chemotherapy. They also reviewed prognostic models developed for prediction of distant metastasis of CRC and described following common predictors: positive lymph nodes, tumor grade or differentiation, tumor histological type, biomarker-carcinoembryonic antigen, age, gender and clinical treatment (such as surgery, chemotherapy and radiotherapy) (Xu et al. 2020). Dumont et al. showed that local recurrence was associated with a higher incidence of lymph node involvement (Dumont et al. 2020). Wiesmueller et al. revealed that positive lymph node status and/or advanced pT category were independent risk factors for recurrence within 16 months on multivariate analysis (Wiesmueller et al. 2021). Stipa et al. showed that local recurrence risk for patients with colon cancer was determined by histological tumor grade (Stipa et al. 1991). Schellenberg et al. described predictive risk factors of the colorectal cancer as T stage, N stage, vascular invasion and positive margins in univariable analysis, however they didn’t find any significant effect of age, type or histological grade of the tumor (Schellenberg et al. 2022). Holt et al. showed that higher recurrence was associated with tumors with a mucinous and/or signet component, patients with positive nodes and patients who had less than 12 lymph nodes examined in multivariate analysis (Holt et al. 2021). van der Linden et al. stated that poorly differentiated histology and MSI status were significant relevant risk factors for local recurrence or distant metastasis with patients diagnosed with Stage I and II CRC. They didn’t find any difference on recurrence for the angioinvasion, lymph invasion or amount of lymph nodes (van der Linden et al. 2020). Michelassi et al. showed that lymphatic or capillary microinvasion is related with local recurrence (Michelassi et al. 1990). Tokodai et al. revealed that lymphatic invasion in stage II patients is independent predictor of local or distant recurrence (Tokodai et al. 2016). Shanmugam et al. showed that increased number of resected lymph nodes is associated with reduced risk of recurrence for Stage II and III CRC (Shanmugam et al. 2011). Tsai et al. showed that presence of vascular invasion and number of examined lymph node were significantly prognostic factors of the postoperative relapse after resection of Stage II CRC, however, they didn’t find any significant differences regarding the gender, age, tumor size, tumor grade and tumor type (Tsai et al. 2008). Guo et al. constructed nomograms to determine prognostic role of different variables including distant metastasis (Guo et al. 2020). Based on their nomogram, different independent factors have their own score and effect on distant metastasis including age, tumor size, N stage, tumor grade and CEA.
Our data showed an association between tumor deposits and heightened occurrences of both local and distant recurrence. This finding is substantiated by prior studies. However, our study showed that the number of tumor deposit has a significant effect. Patients who have ≥ 4 tumor deposit tend to experience local recurrence/distant metastasis more than patients with < 4 tumor deposit.
Given that our study is a retrospective analysis conducted at a single institution, it is important to exercise caution when generalizing our results to the broader population. Additionally, the characteristics of TDs, such as size and histological origins (perivascular, perineural etc.) were not considered. Additionally, this study does not specify distant metastasis types such as liver, lung etc.
Conclusions
In summary, individuals with colorectal cancer and ≥ 4 TDs demonstrate a higher propensity for both local and distant recurrence compared to those with < 4TDs. Therefore, we propose an amendment to the AJCC classification of colon cancer, upgrading LN − ≥ 4 TD + into a new subset category which could be named’’N2c’’. And patients with LN − , 1 to 3 TD + would remain staged as N1c. Also, it is required to conduct extensive, multi-center clinical investigations to identify the correlation between TDs and locally advanced colorectal cancer.
Data availability
All data and materials are available upon request from the corresponding author.
References
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, et al. (Eds.). AJCC Cancer Staging Manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017. Cited 1/15/2024.
Chen W, Zheng R, Baade P, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.
Delattre JF, Cohen R, Henriques J, et al. Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR). J Clin Oncol. 2020;38(15):1702–10.
Dumont F, Joseph S, Lorimier G, et al. Intra-abdominal recurrence from colorectal carcinoma: Differences and similarities between local and peritoneal recurrence. Surg Oncol. 2020;32:23–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.suronc.2019.10.018.
Guo K, Feng Y, Yuan L, et al. Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer. Cancer Med. 2020;9(14):5095–113. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/cam4.3114.
Holt J, Schwalb H, Elbourne H, Te Marvelde L, Reid C. Risk factors for recurrence in colorectal cancer: a retrospective analysis in a regional Australian hospital. ANZ J Surg. 2021;91(11):2482–6. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/ans.17209.
Michelassi F, Vannucci L, Ayala JJ, Chappel R, Goldberg R, Block GE. Local recurrence after curative resection of colorectal adenocarcinoma. Surgery. 1990;108(4):787–93.
Nagayoshi K, Ueki T, Nishioka Y, et al. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more. Dis Colon Rectum. 2014;57(4):467–74.
Nagtegaal ID, Quirke P. Colorectal tumour deposits in the mesorectum and pericolon; a critical review. Histopathology. 2007;51(2):141–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1111/j.1365-2559.2007.02720.x.
Nagtegaal ID, Tot T, Jayne DG, et al. Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol. 2011;29(18):2487–92. https://doiorg.publicaciones.saludcastillayleon.es/10.1200/JCO.2011.34.6429.
Nagtegaal ID, Knijn N, Hugen N, et al. Tumor Deposits in Colorectal Cancer: Improving the Value of Modern Staging-A Systematic Review and Meta-Analysis. J Clin Oncol. 2017;35(10):1119–27.
National Comprehensive Cancer Network. Colon Cancer (Version 4.2023). https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Accessed January 15, 2024.
Schellenberg AE, Moravan V, Christian F. A competing risk analysis of colorectal cancer recurrence after curative surgery. BMC Gastroenterol. 2022;22(1):95. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12876-022-02161-9. Published 2022 Mar 3.
Shanmugam C, Hines RB, Jhala NC, et al. Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer. J Hematol Oncol. 2011;4:25. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/1756-8722-4-25. Published 2011 May 28.
Siegel R, Miller K, Fuchs H, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
Stipa S, Nicolanti V, Botti C, et al. Local recurrence after curative resection for colorectal cancer: frequency, risk factors and treatment. J Surg Oncol Suppl. 1991;2:155–60. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/jso.2930480532.
Tateishi S, Arima S, Futami K, et al. A clinicopathological investigation of “tumor nodules” in colorectal cancer. Surg Today. 2005;35:377–84.
Tokodai K, Narimatsu H, Nishida A, et al. Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern. J Surg Oncol. 2016;114(3):368–74. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/jso.24320.
Tsai HL, Cheng KI, Lu CY, et al. Prognostic significance of depth of invasion, vascular invasion and numbers of lymph node retrievals in combination for patients with stage II colorectal cancer undergoing radical resection. J Surg Oncol. 2008;97(5):383–7. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/jso.20942.
Ueno H, Hashiguchi Y, Shimazaki H, Shinto E, Kajiwara Y, Nakanishi K, et al. Peritumoral deposits as an adverse prognostic indicator of colorectal cancer. Am J Surg. 2014;207(1):70–7.
van der Linden RLA, Rijstenberg LL, van der Linden JC, et al. Node negative colorectal cancer patients: assesment of high-risk features on recurrence. Pathol Res Pract. 2020;216(9): 153034. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.prp.2020.153034.
Wiesmueller F, Schuetz R, Langheinrich M, et al. Defining early recurrence in patients with resected primary colorectal carcinoma and its respective risk factors. Int J Colorectal Dis. 2021;36(6):1181–91. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00384-021-03844-7.
Wu W, Zeng S, Zhang X, et al. The value of tumor deposits in evaluating colorectal cancer survival and metastasis: a population-based retrospective cohort study. World J Surg Oncol. 2022;20(1):41.
Xu W, He Y, Wang Y, et al. Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):172. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12916-020-01618-6. Published 2020 Jun 26.
Institutional review board statement
I confirm that all relevant ethical guidelines have been followed, and any necessary IRB (Institutional Review Board) and/or ethics committee approvals have been obtained (the Feinstein Institutes for Medical Research/Northwell Health system located in New York City, USA). Ethical approval was waived; IRB approval number: 24–0186.
Informed consent statement
Not applicable.
Funding
This research received no external funding.
Author information
Authors and Affiliations
Contributions
Conceptualization, A.B. (Ahmed Bendari), E.U., H.H., A.B. (Alaa Bendari), and M.H.; methodology, A.B. (Ahmed Bendari) and H.H.; software, A.B. (Ahmed Bendari), and H.H.; validation, A.B. (Ahmed Bendari), H.H., and S.K.K.; formal analysis, A.B. (Ahmed Bendari), E.U., H.H., A.B. (Alaa Bendari); investigation, A.B. (Ahmed Bendari), E.U. H.H., R.A., A.B. (Alaa Bendari), and R.D.J. ; resources, R.A., F.K., E.U.; data curation, A.B.(Ahmed Bendari), R.A., E.U., and F.K.; writing—original draft preparation, A.B. (Ahmed Bendari), E.U.; writing—review and editing, A.B. (Ahmed Bendari), E.U., A.B. (Alaa Bendari), R.D.J., and M.H.; visualization, A.B. (Ahmed Bendari); supervision, A.B. (Ahmed Bendari) and M.H.; project administration, A.B. (Ahmed Bendari); funding acquisition, N/A. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Bendari, A., Ucar, E., Bendari, A. et al. A high number of tumor deposits (≥ 4) is an isolated predictor of local recurrence and distant metastasis in non-metastatic colorectal cancer: a single center study. Surg Exp Pathol 7, 30 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s42047-024-00173-1
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s42047-024-00173-1